{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:09:23Z","timestamp":1758636563643,"version":"3.44.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.transproceed.2019.03.051","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T17:00:52Z","timestamp":1565197252000},"page":"2265-2267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Retrospective Investigation of Grafted Kidney Function After Reversal of Neuromuscular Blockade Using Neostigmine or Sugammadex"],"prefix":"10.1016","volume":"51","author":[{"given":"Reyhan","family":"Arslantas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu Eler","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.03.051_bib1","first-page":"266","article-title":"A\u00a0novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host","volume":"41","author":"Bom","year":"2002","journal-title":"Angewandte Chemie"},{"key":"10.1016\/j.transproceed.2019.03.051_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/ern.09.22","article-title":"Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block","volume":"9","author":"Hogg","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.transproceed.2019.03.051_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12882-017-0553-2","article-title":"Renal association clinical practice guideline in post-operative care in the kidney transplant recipient","volume":"18","author":"Baker","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2019.03.051_bib4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1213\/ANE.0000000000000108","article-title":"Dexamethasone produces dose-dependent inhibition of sugammadex reversal in in\u00a0vitro innervated primary human muscle cells","volume":"118","author":"Rezonja","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.transproceed.2019.03.051_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00281-011-0259-7","article-title":"Steroids in kidney transplant patients","volume":"33","author":"Steiner","year":"2011","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.transproceed.2019.03.051_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/bja\/aet586","article-title":"Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg\u22121 for reversal of deep neuromuscular blockade in patients with severe renal impairment","volume":"114","author":"Panhuizen","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.transproceed.2019.03.051_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EJA.0000000000000338","article-title":"The use of rocuronium and sugammadex in paediatric renal transplantation: two case reports","volume":"33","author":"Carlos","year":"2016","journal-title":"Eur J Anaesthesiol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518317664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518317664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:30:28Z","timestamp":1758576628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518317664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0041134518317664"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.03.051","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective Investigation of Grafted Kidney Function After Reversal of Neuromuscular Blockade Using Neostigmine or Sugammadex","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}